NCT04326075View on ClinicalTrials.gov

Early CPAP in COVID-19 Patients With Respiratory Failure.

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

December 15, 2022

Conditions
CPAP VentilationCOVID-19Emergency Departments
Interventions
DEVICE

CPAP treatment

CPAP should be performed as soon as possible and only with a helmet, using a positive end-expiratory pressure (PEEP) between 8 and 14 cmH2O and an inspired oxygen fraction (FiO2) between 40 and 60%.

Trial Locations (1)

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT04326075 - Early CPAP in COVID-19 Patients With Respiratory Failure. | Biotech Hunter | Biotech Hunter